Portfolio (Quarterly)
Guide ↗
Persistent Asset Partners Ltd
· CIK 0002056052| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 341 | — CALL | JOHNSON & JOHNSON | — | 133.0 | $3K | 0.00% | NEW | — | $21.50 | — |
| 342 | — CALL | LEGEND BIOTECH CORP | — | 184.0 | $3K | 0.00% | NEW | — | $15.00 | — |
| 343 | — CALL | ISHARES SILVER TR | — | 35.0 | $2K | 0.00% | NEW | — | $60.51 | — |
| 344 | — PUT | CASSAVA SCIENCES INC | — | 30.0 | $2K | 0.00% | +6.0 | +25.0% | $54.33 | — |
| 345 | — CALL | ULTRAGENYX PHARMACEUTICAL IN | — | 266.0 | $1K | 0.00% | -81.0 | -23.3% | $4.26 | — |
| 346 | — CALL | INTELLIA THERAPEUTICS INC | — | 570.0 | $866.0 | — | -506.0 | -47.0% | $1.52 | — |
| 347 | — CALL | SOLENO THERAPEUTICS INC | — | 143.0 | $425.0 | — | +28.0 | +24.4% | $2.97 | — |
| 348 | — CALL | INTUITIVE SURGICAL INC | — | 4.0 | $401.0 | — | NEW | — | $100.25 | — |
| 349 | — CALL | REVIVA PHARMACEUTCLS HLDGS I | — | 1,138.0 | $228.0 | — | NEW | — | $0.20 | — |
| 350 | — CALL | KRATOS DEFENSE & SEC SOLUTIO | — | 10.0 | $225.0 | — | NEW | — | $22.50 | — |
| 351 | — CALL | TESLA INC | — | 7.0 | $130.0 | — | -3.0 | -30.0% | $18.57 | — |
| 352 | — CALL | ATYR PHARMA INC | — | 36.0 | $129.0 | — | -261.0 | -87.9% | $3.58 | — |
| 353 | — CALL | CATERPILLAR INC | — | 9.0 | $72.0 | — | NEW | — | $8.00 | — |
| 354 | — CALL | MEREO BIOPHARMA GROUP PLC | — | 5,359.0 | $57.0 | — | +2K | +53.1% | $0.01 | — |
| 355 | — CALL | GOLDMAN SACHS GROUP INC | — | 2.0 | $36.0 | — | NEW | — | $18.00 | — |
| 356 | — CALL | EDITAS MEDICINE INC | — | 862.0 | $34.0 | — | +169.0 | +24.4% | $0.04 | — |
| 357 | — CALL | RECURSION PHARMACEUTICALS IN | — | 1,999.0 | $20.0 | — | +393.0 | +24.5% | $0.01 | — |
| 358 | — CALL | ALTIMMUNE INC | — | 1,324.0 | $13.0 | — | +260.0 | +24.4% | $0.01 | — |
| 359 | — CALL | VISTAGEN THERAPEUTICS INC | — | 287.0 | $3.0 | — | +56.0 | +24.2% | $0.01 | — |
| 360 | — CALL | APPLIED THERAPEUTICS INC | — | 55.0 | $1.0 | — | +11.0 | +25.0% | $0.02 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
56.7%
Technology
14.5%
Financial Services
14.2%
Consumer Cyclical
3.6%
Communication Services
3.5%
Energy
3.5%
Basic Materials
3.0%
Consumer Defensive
0.6%
Industrials
0.4%